Both in Pharmaceuticals
Impact BioMedical vs ProMIS Neurosciences Inc. Common Shares (ON)
Over the past year IBO returned −39.0% and PMN returned −65.4%; their daily moves had a correlation of 0.04.
IBO −39.0% PMN −65.4%Growth of $1, one year, split-adjusted
| Metric | IBO | PMN |
|---|---|---|
| Price | $4.10 | $3.52 |
| Market cap | $35.0M | $31.6M |
| Today | +1.99% | +3.23% |
| 1 month | −12.4% | −61.8% |
| 6 months | −48.8% | −68.0% |
| Year to date | −35.7% | −48.4% |
| 1 year | −39.0% | −65.7% |
| Revenue growth (YoY) | −57.1% | — |
| Gross margin | −533.3% | — |
| Net margin | −23300.0% | — |
| P/E (TTM) | 44.4× | — |
| Price / sales | 1,000.8× | — |
| Net cash | $10.0K | $53.5M |
| Dividend yield | — | — |
| Volatility (60d) | 736.6% | 262.2% |
| Short % of float | 2.6% | 3.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).